To solve this, advanced delivery methods have been developed
By 2024, Ozempic had surpassed Trulicity, also approved for type 2 diabetes (not obesity) to make up the largest share of GLP-1 prescriptions and spending (39% in 2024)
Dehydration risk increases in patients with reduced oral intake or concurrent illness
These agents, known for their dual impact on both immune modulation and metabolic improvement, offer a unique therapeutic potential in managing immune-mediated inflammatory diseases (47)
Bupropion does not typically cause temperature sensitivity, but the stimulant-like properties can cause sweating in some users, creating a confusing situation where someone feels cold from tirzepatide weight loss but sweats from bupropion norepinephrine activity
Each GLP-1 medication works in different manners, and there are two main types